botox and glp 1 Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic aesthetic indications The Face Effect of GLP-1
Description
Yes switching between semaglutide and tirzepatide is a normal part of the process
however, following treatment withdrawal, body weight increased, with 11.6% of the lost weight regained after 52 weeks [16]
2025;41(2):e70037
It is the leading cause of irreversible blindness globally, with projections indicating it could affect over 100 million individuals by 2040 (74)
Additionally, a systematic review by Drant et al
Additionally, inform your doctor if you are taking GLP-1 drugs and are scheduled for surgery or a procedure requiring general anesthesia, as these drugs slow digestion and may necessitate discontinuation prior to the procedure.
